Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Minimizing losses in cryptocurrency trading is key to success. Explore effective strategies to enhance your trading and maximize profits.
17,032 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Federal health officials issued a warning about misleading statements from biotech billionaire Patrick Soon-Shiong re...
Morgan Stanley boosted its price target on Planet Labs to $35, citing rising defense and intelligence demand and a ro...
Billionaire Bill Ackman recently shifted gears, selling a former cornerstone stake to fund two AI stock bets. This mo...
Adobe posted solid quarterly results but faces mounting downgrades as analysts question AI monetization, pricing powe...
Oil trading desks warn that disruptions through the Strait of Hormuz could trigger a global crude supply squeeze as A...
Occidental Petroleum surges in 2026 on debt cleanup after the OxyChem sale, with oil prices supportive but questions ...
If you’ve got $5,000 to invest, these three AI-driven stock picks offer a balanced blend of growth potential and prac...
As factories re-shore production in 2026, three ETFs track the trend with different tilts. Here is how AIRR, PAVE, an...
Bitcoin shows a bullish weekly signal as a MACD cross fuels renewed upside bets. The coin sits around $84,000 with tr...
Explore Viemed's 2026 earnings outlook with a practical, numbers-driven view. Learn the key drivers, risks, and how t...
As Zillow prepares for 2026 earnings season, investors crave clarity on growth, margins, and how the housing cycle co...